{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:59:31Z","timestamp":1791273571505,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.diagmicrobio.2012.02.001","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T06:36:43Z","timestamp":1336718203000},"page":"45-48","source":"Crossref","is-referenced-by-count":272,"title":["The changing epidemiology of healthcare-associated candidemia over three decades"],"prefix":"10.1016","volume":"73","author":[{"given":"Daniel","family":"Diekema","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Arbefeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Boyken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kroeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pfaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0005","article-title":"Impact of therapy on mortality across Candida spp in patients with invasive candidiasis from randomized clinical trials: a patient level analysis","author":"Andes","year":"2010"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1128\/JCM.37.3.531-537.1999","article-title":"Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital","volume":"37","author":"Berrouane","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0015","series-title":"Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard - third edition, M27-A3","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jinf.2007.10.014","article-title":"Increasing incidence of Candida parapsilosis candidemia with caspofungin usage","volume":"56","author":"Forrest","year":"2008","journal-title":"J Infect"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0025","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0030","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/00365541003699631","article-title":"Prior antimicrobial exposure and the risk of bloodstream infection with fluconazole-non-susceptible Candida strains","volume":"42","author":"Hebert","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0035","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1086\/591861","article-title":"Antimicrobial resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007","volume":"29","author":"Hidron","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0040","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1439-0507.2010.01941.x","article-title":"Is age a risk factor for Candida glabrata colonization?","volume":"54","author":"Malani","year":"2011","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009 update by the IDSA","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","article-title":"In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0065","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1128\/JCM.06112-11","volume":"50","author":"Pfaller","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.drup.2011.01.004","article-title":"Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria","volume":"14","author":"Pfaller","year":"2011","journal-title":"Drug Resist Update"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0070","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1086\/342300","article-title":"Secular trend of hospital acquired candidemia among intensive care unit patients in the United States during 1989-1999","volume":"35","author":"Trick","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0075","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1001\/archinte.1988.00380120094019","article-title":"Hospital acquired candidemia: attributable mortality and excess length of stay","volume":"148","author":"Wey","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diagmicrobio.2012.02.001_bb0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/421946","article-title":"Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study","volume":"39","author":"Wisplinghoff","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312000661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889312000661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T13:01:56Z","timestamp":1594126916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889312000661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0732889312000661"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.02.001","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}